These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9673596)

  • 1. High-dose riboflavin for migraine prophylaxis.
    Mattimoe D; Newton W
    J Fam Pract; 1998 Jul; 47(1):11. PubMed ID: 9673596
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose riboflavin for the prevention of migraine: can we afford to ignore it?
    Davis JS
    Intern Med J; 2004 Jun; 34(6):372-3; author reply 373. PubMed ID: 15228409
    [No Abstract]   [Full Text] [Related]  

  • 3. Topiramate: new indication. Migraine prevention: best avoided.
    Prescrire Int; 2006 Aug; 15(84):132-3. PubMed ID: 16989025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial.
    Sándor PS; Di Clemente L; Coppola G; Saenger U; Fumal A; Magis D; Seidel L; Agosti RM; Schoenen J
    Neurology; 2005 Feb; 64(4):713-5. PubMed ID: 15728298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Utilizing the strength(s) of rizatriptan 10 mg: cost effective against migraine attacks].
    MMW Fortschr Med; 2009 Mar; 151(13):92-3. PubMed ID: 19504831
    [No Abstract]   [Full Text] [Related]  

  • 6. [Migraine and prevention of migraine: the value of magnesium].
    Schuck P; Böhmer K; Resch KL
    Schweiz Med Wochenschr; 1999 Jan; 129(3):63-70. PubMed ID: 10065508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose riboflavin treatment is efficacious in migraine prophylaxis: an open study in a tertiary care centre.
    Boehnke C; Reuter U; Flach U; Schuh-Hofer S; Einhäupl KM; Arnold G
    Eur J Neurol; 2004 Jul; 11(7):475-7. PubMed ID: 15257686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Shuhendler AJ; Lee S; Siu M; Ondovcik S; Lam K; Alabdullatif A; Zhang X; Machado M; Einarson TR
    Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feverfew for migraine prophylaxis.
    Henneicke-von Zepelin HH
    Headache; 2006 Mar; 46(3):531. PubMed ID: 16618282
    [No Abstract]   [Full Text] [Related]  

  • 10. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicentre, double-blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type A (BoNTA) for the prophylaxis of episodic migraine headaches.
    Relja M; Poole AC; Schoenen J; Pascual J; Lei X; Thompson C;
    Cephalalgia; 2007 Jun; 27(6):492-503. PubMed ID: 17428299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of magnesium, coenzyme Q10, riboflavin, and vitamin B12 in migraine prophylaxis.
    Bianchi A; Salomone S; Caraci F; Pizza V; Bernardini R; D'Amato CC
    Vitam Horm; 2004; 69():297-312. PubMed ID: 15196887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized double-blind placebo-controlled trial of thioctic acid in migraine prophylaxis.
    Magis D; Ambrosini A; Sándor P; Jacquy J; Laloux P; Schoenen J
    Headache; 2007 Jan; 47(1):52-7. PubMed ID: 17355494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trial.
    Cady RK; Mathew N; Diener HC; Hu P; Haas M; Novak GP;
    Headache; 2009 Feb; 49(2):216-26. PubMed ID: 19222595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of high-dose riboflavin in migraine prophylaxis.
    Yee AJ
    Neurology; 1999 Jan; 52(2):431-2. PubMed ID: 9932987
    [No Abstract]   [Full Text] [Related]  

  • 16. Economic analysis of triptan therapy for acute migraine: a Medicaid perspective.
    Mullins CD; Subedi PR; Healey PJ; Sanchez RJ
    Pharmacotherapy; 2007 Aug; 27(8):1092-101. PubMed ID: 17655509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose riboflavin as a prophylactic treatment of migraine: results of an open pilot study.
    Schoenen J; Lenaerts M; Bastings E
    Cephalalgia; 1994 Oct; 14(5):328-9. PubMed ID: 7828189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin as preventive treatment for migraine: a randomized double-blind study.
    Petri S; Tölle T; Straube A; Pfaffenrath V; Stefenelli U; Ceballos-Baumann A;
    Eur Neurol; 2009; 62(4):204-11. PubMed ID: 19622887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
    Mathew NT; Landy S; Stark S; Tietjen GE; Derosier FJ; White J; Lener SE; Bukenya D
    Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.